Technical Analysis for MPME - Medisun Precision Medicine Ltd.

Grade Last Price % Change Price Change
grade F 0.019 -19.49% -0.0046
MPME closed down 19.49 percent on Tuesday, August 13, 2019, on 2.13 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MPME trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Gilligan's Island Buy Setup Bullish Swing Setup -19.49%
New 52 Week Low Weakness -19.49%
Wide Bands Range Expansion -19.49%
Gapped Down Weakness -19.49%

Older signals for MPME ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Medisun Precision Medicine Ltd., a development stage company, focuses on developing targeted therapies primarily in the United States. It is developing ACX-31, a program to deliver temozolomide, a chemotherapy drug in combination with BCNU directly to brain tumor sites; and BranchPoint, a microinjection brain catheter for use in the delivery of therapeutics to the human brain. The company has a collaboration agreement with DelMar Pharmaceuticals, Inc. to develop ACX-31; and a consulting agreement with Lim Development Group to develop and commercialize the BranchPoint device. The company was formerly known as Accurexa, Inc. and changed its name to Medisun Precision Medicine Ltd. in June 2017. Medisun Precision Medicine Ltd. was incorporated in 2012 and is based in Majuro, the Republic of the Marshall Islands.
Medicine RTT Cancer Clinical Medicine Chemotherapy Oncology Cancer Treatments Brain Tumor
Is MPME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.3293
52 Week Low 0.0184
Average Volume 11,390
200-Day Moving Average 0.0908
50-Day Moving Average 0.0441
20-Day Moving Average 0.03
10-Day Moving Average 0.0234
Average True Range 0.0056
ADX 12.65
+DI 43.0218
-DI 46.0948
Chandelier Exit (Long, 3 ATRs ) 0.05320000000000001
Chandelier Exit (Short, 3 ATRs ) 0.0352
Upper Bollinger Band 0.0463
Lower Bollinger Band 0.0137
Percent B (%b) 0.16
BandWidth 108.666667
MACD Line -0.0063
MACD Signal Line -0.0064
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0205
Resistance 3 (R3) 0.0207 0.0203 0.0203
Resistance 2 (R2) 0.0203 0.0200 0.0203 0.0202
Resistance 1 (R1) 0.0197 0.0197 0.0195 0.0195 0.0201
Pivot Point 0.0193 0.0193 0.0193 0.0193 0.0193
Support 1 (S1) 0.0187 0.0190 0.0185 0.0185 0.0179
Support 2 (S2) 0.0183 0.0187 0.0183 0.0178
Support 3 (S3) 0.0177 0.0183 0.0178
Support 4 (S4) 0.0175